Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

Cited In for PubMed (Select 17580330)

1.

The GABA Hypothesis in Essential Tremor: Lights and Shadows.

Gironell A.

Tremor Other Hyperkinet Mov (N Y). 2014 Jul 16;4:254. doi: 10.7916/D8SF2T9C. eCollection 2014.

2.

Pharmacotherapy of essential tremor.

Hedera P, Cibulčík F, Davis TL.

J Cent Nerv Syst Dis. 2013 Dec 22;5:43-55. doi: 10.4137/JCNSD.S6561. Review.

3.

Methodological issues in clinical drug development for essential tremor.

Carranza MA, Snyder MR, Elble RJ, Boutzoukas AE, Zesiewicz TA.

Tremor Other Hyperkinet Mov (N Y). 2012;2. pii: tre-02-68-402-1. Epub 2012 Aug 6.

4.

Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology.

Zesiewicz TA, Elble RJ, Louis ED, Gronseth GS, Ondo WG, Dewey RB Jr, Okun MS, Sullivan KL, Weiner WJ.

Neurology. 2011 Nov 8;77(19):1752-5. doi: 10.1212/WNL.0b013e318236f0fd. Epub 2011 Oct 19. Review.

5.

Use of antiepileptic drugs for hyperkinetic movement disorders.

Siniscalchi A, Gallelli L, De Sarro G.

Curr Neuropharmacol. 2010 Dec;8(4):359-66. doi: 10.2174/157015910793358187.

6.

Diagnosis and management of essential tremor and dystonic tremor.

Gironell A, Kulisevsky J.

Ther Adv Neurol Disord. 2009 Jul;2(4):215-22. doi: 10.1177/1756285609104791.

7.

Overview of essential tremor.

Zesiewicz TA, Chari A, Jahan I, Miller AM, Sullivan KL.

Neuropsychiatr Dis Treat. 2010 Sep 7;6:401-8.

8.

A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.

Tzellos TG, Papazisis G, Toulis KA, Sardeli Ch, Kouvelas D.

Hippokratia. 2010 Apr;14(2):71-5.

9.

Pharmacologic management of essential tremor.

Lees M, Regier L, Jensen B.

Can Fam Physician. 2010 Mar;56(3):250-2. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk